Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Enliven Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company Focused On The Discovery And Development Of Small Molecule Therapeutics. The Product Candidates Of The Company Include Elvn-001 Is Designed To Specifically Target The Bcr-Abl Fusion Gene Product, The Oncogenic Driver For Patients With Chronic Myeloid Leukemia (Cml), Elvn-002 Is Designed To Inhibit Wild-Type Her2 And Key Mutations Of Her2.